Posted: July 26th, 2016
1. Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone LongActing Injectable vs Quetiapine: Results of a LongTerm, OpenLabel, Randomized Clinical Trial 2.A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia 3. An Exploratory, OpenLabel, Randomized Trial Comparing Risperidone LongActing Injectable with Oral Antipsychotic Medication in the Treatment of Early Psychosis 4.Depot and oral antipsychotics: patient preferences and attitudes are not the same thing 5.Descriptive analyses of the aripiprazole arm in the risperidone longacting injectable versus quetiapine relapse prevention trial (ConstaTRE) 6.Firstgeneration antipsychotic longacting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies 7.Longacting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebocontrolled relapse prevention studies 8.LongActing Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A MetaAnalysis of Randomized Trials 9.LongActing Risperidone and Oral Antipsychotics in Unstable Schizophrenia 10.Maintenance Treatment With LongActing Injectable Risperidone in FirstEpisode Schizophrenia: A Randomized Effectiveness Study 11.Olanzapine LongActing Injection: A 24Week, Randomized, DoubleBlind Trial of Maintenance Treatment in Patients With Schizophrenia 12.Oral versus depot antipsychotic drugs for schizophreniaA critical systematic review and metaanalysis of randomised longterm trials 13.Oral versus LongActing Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review
Place an order in 3 easy steps. Takes less than 5 mins.